How much revenue did Clal Biotechnology Industries generate this year?
Clal Biotechnology Industries has achieved a revenue of 9.15 M ILS this year.
Clal Biotechnology Industries Revenue 2024
Clal Biotechnology Industries Revenue
9.15 M ILS
Clal Biotechnology Industries Dividend yield
0.44 %
Ticker
CBI.TA
ISIN
IL0011042806
In 2024, Clal Biotechnology Industries's sales reached 9.15 M ILS, a -78.23% difference from the 42.03 M ILS sales recorded in the previous year.
The Clal Biotechnology Industries Revenue history
| YEAR | REVENUE (undefined ILS) | GROSS MARGIN (%) |
|---|---|---|
| 2022 | 9.15 | 934,48 |
| 2021 | 42.03 | 203,44 |
| 2020 | 42.93 | 199,18 |
| 2019 | 143.4 | 59,63 |
| 2018 | 77.06 | 77,16 |
| 2017 | 54.5 | 40,49 |
| 2016 | 25.01 | -87,83 |
| 2015 | 31.77 | -33,95 |
| 2014 | 55.79 | -848,49 |
| 2013 | 25.7 | 78,99 |
| 2012 | 51.6 | 100,00 |
| 2011 | 328.8 | 100,00 |
| 2010 | 31.4 | 95,54 |
| 2009 | 183 | 99,78 |
| 2008 | 34.5 | 88,99 |
| 2007 | 19.5 | 438,49 |
| 2006 | 34.3 | 249,29 |
| 2005 | 2.2 | 3886,59 |
Clal Biotechnology Industries Aktienanalyse
What does Clal Biotechnology Industries do?
Clal Biotechnology Industries ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Clal Biotechnology Industries's Sales Figures
The sales figures of Clal Biotechnology Industries originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Clal Biotechnology Industries’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Clal Biotechnology Industries's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Clal Biotechnology Industries’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Clal Biotechnology Industries Stock
How much was the turnover of the company Clal Biotechnology Industries compared to the previous year?
The revenue of Clal Biotechnology Industries has increased by -78.23% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Clal Biotechnology Industries?
The revenue of Clal Biotechnology Industries is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Clal Biotechnology Industries measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Clal Biotechnology Industries so important for investors?
The revenue of Clal Biotechnology Industries is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Clal Biotechnology Industries pay?
Over the past 12 months, Clal Biotechnology Industries paid a dividend of 0.22 ILS . This corresponds to a dividend yield of about 0.44 %. For the coming 12 months, Clal Biotechnology Industries is expected to pay a dividend of 0.22 ILS.
What is the dividend yield of Clal Biotechnology Industries?
The current dividend yield of Clal Biotechnology Industries is 0.44 %.
When does Clal Biotechnology Industries pay dividends?
Clal Biotechnology Industries pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Clal Biotechnology Industries?
Clal Biotechnology Industries paid dividends every year for the past 0 years.
What is the dividend of Clal Biotechnology Industries?
For the upcoming 12 months, dividends amounting to 0.22 ILS are expected. This corresponds to a dividend yield of 0.44 %.
In which sector is Clal Biotechnology Industries located?
Clal Biotechnology Industries is assigned to the 'Health' sector.
Wann musste ich die Aktien von Clal Biotechnology Industries kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Clal Biotechnology Industries from 4/6/2021 amounting to 0.224 ILS, you needed to have the stock in your portfolio before the ex-date on 3/29/2021.
When did Clal Biotechnology Industries pay the last dividend?
The last dividend was paid out on 4/6/2021.
What was the dividend of Clal Biotechnology Industries in the year 2023?
In the year 2023, Clal Biotechnology Industries distributed 0 ILS as dividends.
In which currency does Clal Biotechnology Industries pay out the dividend?
The dividends of Clal Biotechnology Industries are distributed in ILS.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Clal Biotechnology Industries
Our stock analysis for Clal Biotechnology Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clal Biotechnology Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Clal Biotechnology Industries Revenue
- Clal Biotechnology Industries Net Income
- Clal Biotechnology Industries P/E
- Clal Biotechnology Industries P/S
- Clal Biotechnology Industries EBIT
- Clal Biotechnology Industries Dividend
- Clal Biotechnology Industries Stocks
- Clal Biotechnology Industries Market capitalization
- Clal Biotechnology Industries Debt
- Clal Biotechnology Industries Liabilities
- Clal Biotechnology Industries Equity
- Clal Biotechnology Industries AAQS
- Clal Biotechnology Industries Employees
- Clal Biotechnology Industries ROE
- Clal Biotechnology Industries ROA
- Clal Biotechnology Industries ROCE